Correlation Between Alnylam Pharmaceuticals and Ionis Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Alnylam Pharmaceuticals and Ionis Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alnylam Pharmaceuticals and Ionis Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alnylam Pharmaceuticals and Ionis Pharmaceuticals, you can compare the effects of market volatilities on Alnylam Pharmaceuticals and Ionis Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alnylam Pharmaceuticals with a short position of Ionis Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alnylam Pharmaceuticals and Ionis Pharmaceuticals.
Diversification Opportunities for Alnylam Pharmaceuticals and Ionis Pharmaceuticals
0.28 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Alnylam and Ionis is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding Alnylam Pharmaceuticals and Ionis Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ionis Pharmaceuticals and Alnylam Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alnylam Pharmaceuticals are associated (or correlated) with Ionis Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ionis Pharmaceuticals has no effect on the direction of Alnylam Pharmaceuticals i.e., Alnylam Pharmaceuticals and Ionis Pharmaceuticals go up and down completely randomly.
Pair Corralation between Alnylam Pharmaceuticals and Ionis Pharmaceuticals
Given the investment horizon of 90 days Alnylam Pharmaceuticals is expected to generate 1.11 times more return on investment than Ionis Pharmaceuticals. However, Alnylam Pharmaceuticals is 1.11 times more volatile than Ionis Pharmaceuticals. It trades about 0.26 of its potential returns per unit of risk. Ionis Pharmaceuticals is currently generating about -0.07 per unit of risk. If you would invest 23,531 in Alnylam Pharmaceuticals on November 1, 2024 and sell it today you would earn a total of 4,185 from holding Alnylam Pharmaceuticals or generate 17.79% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Alnylam Pharmaceuticals vs. Ionis Pharmaceuticals
Performance |
| Timeline |
| Alnylam Pharmaceuticals |
| Ionis Pharmaceuticals |
Alnylam Pharmaceuticals and Ionis Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Alnylam Pharmaceuticals and Ionis Pharmaceuticals
The main advantage of trading using opposite Alnylam Pharmaceuticals and Ionis Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alnylam Pharmaceuticals position performs unexpectedly, Ionis Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ionis Pharmaceuticals will offset losses from the drop in Ionis Pharmaceuticals' long position.| Alnylam Pharmaceuticals vs. ProQR Therapeutics BV | Alnylam Pharmaceuticals vs. Wave Life Sciences | Alnylam Pharmaceuticals vs. Blueprint Medicines Corp | Alnylam Pharmaceuticals vs. Apellis Pharmaceuticals |
| Ionis Pharmaceuticals vs. Arrowhead Pharmaceuticals | Ionis Pharmaceuticals vs. Biomarin Pharmaceutical | Ionis Pharmaceuticals vs. Incyte | Ionis Pharmaceuticals vs. Apellis Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |